Tag Archive for: Surface Oncology

Coherus Biosciences announced plans Friday to acquire Surface Oncology, a clinical-stage immuno-oncology company, in a deal worth up to $65 million. The acquisition aims to bolster Coherus’ position in cancer therapeutics and expand its product portfolio.